Home / Stock ratings / TFX
Stock rating · Surgical & Medical Instruments & Apparatus
Teleflex Incorporated (TFX) Stock Rating & Analysis
As of September 29, 2026, MELANY rates Teleflex Incorporated 66 out of 100 (Very Promising). Its highest factor score is catalyst setup at 78, and its lowest is business quality at 45.
MELANY ratingRated 2026-09-29TFX · composite score
About Teleflex Incorporated
Teleflex Inc provides medical technology products aimed at improving clinical benefits, enhancing patient and provider safety, and lowering total procedural costs. It designs, develops, manufactures, and supplies medical devices used by hospitals and healthcare providers for high-acuity emergent procedures. Its three reportable segments are Americas, EMEA (Europe, the Middle East and Africa), and Asia (Asia Pacific), with most revenue coming from the Americas.
Rating as of 2026-09-29 · this is a dated snapshot; the live rating is in the app (Pro, free for 30 days). The price above updates in real time.
Why TFX scores 66/100
TFX's 8 factor scores run from 45 to 78, and 3 of them sit above its composite of 66. Here is how TFX breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- PEG ratio 0.16 (< 1 = undervalued)
Margins, returns on capital, and balance-sheet strength.
- Gross margin 56%
Direction and relative strength of the recent share-price trend.
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 3 of last 4 quarters
- Earnings in 30 days (strong beat history)
What Wall Street price targets and revisions are signalling.
- Institutional net buying +8.8%
Near-term events that could move the stock.
- Earnings in 30 days
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
How TFX compares
As of October 13, 2026, Teleflex Incorporated ranks 6th of the 8 companies with a MELANY rating page in its SEC industry group (Surgical & Medical Instruments & Apparatus), where the average score is 68.
Key risks for TFX
- No positive trailing earnings, valuation cannot be anchored to current P/E
Sector and theme context
Teleflex Incorporated sits in the Healthcare sector theme, which MELANY currently rates 42/100 for strength. Theme strength feeds TFX's momentum and catalyst factors above.
TFX trade plan (Pro)
MELANY has a full position plan for Teleflex Incorporated: a smart entry zone, an alert level, position sizing, and quarterly review triggers. It is part of Market Eyes Pro, and the first 30 days are free.
How MELANY rates TFX
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Teleflex Incorporated's 66/100 reflects speculative factor weighting for its profile. Position framework managed by score-based check-ins, not a fixed holding period.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about TFX
Is Teleflex Incorporated (TFX) a buy?
As of 2026-09-29, MELANY rated Teleflex Incorporated Very Promising with a composite score of 66/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Teleflex Incorporated's MELANY score?
Teleflex Incorporated (TFX) has a MELANY composite score of 66/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.
How is the TFX stock rating calculated?
MELANY scores TFX from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Teleflex Incorporated stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Teleflex Incorporated (TFX) Very Promising with a composite of 66/100 as of 2026-09-29. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the TFX stock price forecast?
MELANY does not publish price targets or forecasts for TFX. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 66/100 across eight factors for Teleflex Incorporated, and re-scores automatically as new price, earnings, and fundamental data arrive.
Is TFX stock overvalued or undervalued?
MELANY's valuation factor currently reads 75/100 for Teleflex Incorporated, where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives TFX's read.
What price should I buy TFX at?
Rather than chasing the current price, MELANY computes a smart entry zone for TFX: the price area where risk and reward actually favor a new position, plus an alert level and position sizing. The exact levels are part of Market Eyes Pro, which starts with a 30-day free trial.
What are the risks of buying TFX stock?
The top risks MELANY currently flags for Teleflex Incorporated: No positive trailing earnings, valuation cannot be anchored to current P/E. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Teleflex Incorporated a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 45/100 for Teleflex Incorporated, and earnings track record, at 70/100. The 66/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will TFX stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 58/100 for TFX right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this TFX rating?
The rating on this page is a snapshot of MELANY's read as of 2026-09-29. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores TFX continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, TFX included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.